Translating Research Into Health®

VGTI Florida Launches the Center for Diseases of Aging to Develop Innovative Treatments for a Broad Range of Difficult-to-Treat Diseases

VGTI Florida Launches the Center for Diseases of Aging to Develop Innovative Treatments for a Broad Range of Difficult-to-Treat Diseases

The Vaccine & Gene Therapy Institute of Florida (VGTI Florida), a leading, non-profit biomedical research institute, today announced the launch of its Center for Diseases of Aging (“CDA”), a major initiative to accelerate the discovery and advancement of novel, best-in-class healthcare interventions...

VGTI Florida Aims to Stop Spread of Chikungunya Virus with Novel Vaccine

VGTI Florida Aims to Stop Spread of Chikungunya Virus with Novel Vaccine

While there is currently no FDA-approved vaccine to prevent the spread of the chikungunya virus, the head of viral immunity research at the Vaccine & Gene Therapy Institute of Florida (VGTI Florida), a leading non-profit biomedical research institute, has developed a new platform vaccine technology that is expected to provide complete protection against chikungunya virus infection.

VGTI Florida Researcher Invents Potential Breakthrough Antiviral Compounds for Prevention of Mosquito-Borne Illnesses

VGTI Florida Researcher Invents Potential Breakthrough Antiviral Compounds for Prevention of Mosquito-Borne Illnesses

The Vaccine & Gene Therapy Institute of Florida (VGTI Florida®), a leading non-profit biomedical research institute, today announced a key milestone achievement in developing novel approaches for the prevention of mosquito-borne viral threats...